ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 204 participants.

Also called NCT04503395

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 204 participants (planned count) (from the registry)
Sponsor
  • Medtronic Registry lists this organization as a collaborator
Registry
  • NCT NCT04503395
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States, Austria, Belgium, France, Germany, Italy, Netherlands, Poland, Spain, Switzerland (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT04503395. Randomized; no masking; primary purpose treatment. Start 2021-05-21 (actual); primary completion 2026-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
Acronym
SOCRATES
Condition
Aortic Aneurysm, Abdominal
Intervention (Device)
ESAR treatment: Endograft + Heli-FX Endoanchor
Intervention (Device)
FEVAR treatment : Fenestrated endograft
Lead sponsor
FCRE (Foundation for Cardiovascular Research and Education) (class: other)
Collaborator
Medtronic (class: industry)

Record details

Record id
cardio:ct-nct04503395
Content hash
f9d33c9f025a75ff76be2a0b2238b0de6dce327f3e627811d6956fe11a220dbf